Pharmaceutical Online

Pharmaceutical Online
Share

Pharmaceutical Online

 •  September 22

The (bio)pharma industry bears the burden of redundant processes and high cost of goods sold. While other industries have learned from the principles of quality and statistical control methodology, pharma has been slow on the uptake. Competition is increasing from abroad, generic drugs, biosimilars, and other sectors. And, our archaic healthcare...

Pharmaceutical Online

 •  September 21

Contact The Supplier IPS-Integrated Project Services, LLC (IPS), a leading global provider of engineering, architecture, project controls, construction management, commissioning and qualification services, and G-CON Manufacturing, Inc. the leading provider of prefabricated cleanrooms, today announced the unveiling of the iCON™ brand which...

Pharmaceutical Online

 •  September 21

It is common to have a limited amount of API in the early phase of drug development, which impedes the rapid progression of drug development. Catalent has developed a new approach that enables the use of industrial scale machines from the very beginning and can result in manufacturing cGMP batches with good yields.

Pharmaceutical Online

 •  September 20

CordenPharma, a contract development and manufacturing organization of drug substances and drug products, has completed an early-development suite for highly potent, oral solid dosage products at its site in Plankstadt, Germany. The new facility allows for the production of small batches, from 100 g to approximately 1,000 g. CordenPharma...

Pharmaceutical Online

 •  September 20

This bulletin discusses ribbon blender features that can reduce cross-contamination risks between batches and improve cleanability. Among the available options is the design for a completely removable agitator which enables high speed product changeover. Reducing contamination risks in sensitive applications A well-designed ribbon blender holds...

Pharmaceutical Online

 •  September 20

Fujifilm Diosynth Biotechnologies, a contract development and manufacturing organization of biologic-based drug substances, has opened its 10,000-square foot, cell-culture process development laboratories in Wilton Center, Teesside, England. These laboratories were realized through a 1 billion JPY ($9M) investment, which is part of the greater 14...

Pharmaceutical Online

 •  September 19

Industry Insights Regulations For Mapping Temperature And Humidity Of Pharmaceuticals Q&A | By Bruce McDuffee, Rotronic Instrument Corp. There are several guidelines from a myriad of agencies around the world that are available that cover environmental monitoring and mapping in life sciences. The Increasing Impact Of Single-Use Equipment In Pharma...

Pharmaceutical Online

 •  September 19

Contact The Supplier Positions Catalent Biologics as a Leading Partner from Development to Commercialization Catalent, Inc., the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products, recently announced it has reached an agreement to acquire Bloomington, Indiana-based...

Pharmaceutical Online

 •  September 19

A major pharmaceutical company in North America with manufacturing in the US, Canada and abroad had a problem, which was not unique to them. Their manufacturing process engineers could not reliably verify that their pouch packages were sealed properly and the product could potentially ship with questionable packaging which failed stability testing....

Pharmaceutical Online

 •  September 19

By Maik W. Jornitz, President, G-CON Manufacturing Lately, the pharmaceutical industry has become increasingly interested in flexible facilities. There are many reasons why such facilities are needed, for example, for new drug development, or to accommodate changes in process technologies, such as the implementation of single-use process equipment....